MBBS, MMed, MRCP(UK)
Specialty: Gastroenterology ＆ Hepatology
Sub-specialties: Therapeutic Endoscopy, Small Bowel Enteroscopy, Capsule Endoscopy
Conditions Treated by this Doctor:
Inflammatory Bowel Disease.
Dr Shim Hang Hock is a graduate of University of Southampton School of Medicine. He was trained and has since been practicing in Singapore General Hospital. During which, Dr Shim completed his postgraduate medical degree in internal medicine [MRCP (UK) and M.Med] and gastroenterology subspecialty training. Dr Shim subsequently advanced his training in Inflammatory Bowel Disease (IBD) by completing a year of fellowship at University of Calgary, Canada, one of the largest IBD units in the world. His practice specialises in the care of patients with gastrointestinal and hepatology disorders, in particular, patients with complex inflammatory bowel disease refractory to conventional treatment, and special population including pregnancy in IBD.
Dr Shim is currently a consultant in the Department of Gastroenterology and Hepatology, Singapore General Hospital.
HH Shim, CH Seow. Chapter 10. Cessation of biologics in IBD. Can it be done? Treatment of Inflammatory Bowel Disease with Biologics. Ed. A Cheifetz, Ed. J Feuerstein. Springer. (In press)
Webber Chan, Hang Hock Shim, Miao Shan Lim, et al. Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability. Digestive and Liver Disease, DOI: http://dx.doi.org/10.1016/j.dld.2017.08.020
Shim HH, Seow CH. Editorial: vedolizumab in pregnancy – is gut selectivity as good for baby as it is for mum? Aliment Pharmacol Ther 2017; 45: 1283–4.
Goh BB, C Kwan, SY Lim, NKK Venkatanarasimha, RA Bakar, TL Krishnamoorthy, HH Shim, KH Tay, WC Chow. Non Alcoholic Fatty Liver Disease–An Asian Community Based Study. Gastroenterology Report 2016 May;4(2):131-5. DOI: 10.1093/gastro/gov047. PubMed: 26463276
Y. Leung *, HH. Shim*, SM. Lee, E. Ehteshami Afshar, N. Sharifi, D. Tanyingoh, M. Aghaei, R. Wilkens, SR. Wilson, KL. Novak, R. Panaccione, and CH. Seow. Bowel Sonography Is Useful In Detecting Subclinical Inflammation In Pregnant Women With Crohn’s Disease And Changes Clinical Management; oral presentation; Asian Organization of Crohn’s and Colitis (AOCC) 2017
HM Al-Farhan, AK Al-Darmaki, HH Shim, CH Seow, GG Kaplan, R.Pannacione, SR Wilson, J Halasz and KL Novak. Point of Care Ultrasound Accurately Distinguishes Inflammatory From Non Inflammatory Disease In Patients Presenting With Abdominal Pain and Diarrhea; poster abstract, Digestive Disease Week (DDW) 2017; poster abstract, European Crohn’s and Colitis (ECCO) 2017
HH Shim*, C Ma*, H AlFarhan, A Al-Darmaki, JXQ Pang, CH Seow, RN Fedorak, SM Devlin, LA Dieleman, GG Kaplan, KL Novak, KI Kroeker, BP Halloran, and R Panaccione. Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn’s Disease Patients: A Multicentre Canadian Provincial Experience; poster abstract; Digestive Disease Week (DDW) 2017
SM Lee, ZY Zhang, ME Kuenzig, HH Shim, R Panaccione, GG Kaplan, CH Seow. Smoking Does Not Influence the Effectiveness of Anti-Tumor Necrosis Factor Therapies in Patients with Crohn’s Disease in the Short Term: A Systematic Review and Meta-Analysis; poster abstract; Canadian Digestive Disease Week (CDDW) 2017
HH Shim*, C Ma*, H AlFarhan, AK Aldarmaki, JXQ Pang, CH Seow, RN Fedorak, SM Devlin, LA Dieleman, GG Kaplan, KL Novak, KI Kroeker, BP Halloran, R Panaccione. Postoperative outcomes among ustekinumab treated Crohn’s disease patients: a multicentre Canadian provincial experience; poster abstract; Canadian Digestive Disease Week (CDDW) 2017
Chuah SW, Delord P, Sutiman N, Leong WF, Kong SC, Schwender B, Chan PW, Shim HH, Aw HY, Ong EH, Hartono J, Lim WC, Ong C, Ong PL, Ling KL, Chowbay B. Therapeutic drug monitoring of thiopurines in the management of Asian patients with Inflammatory Bowel Disease; Poster Abstract; ECCO 2016; best oral presentation; APAGE 2016
Sutiman N, Ling KL, Chuah SW, Leong WF, Nadiger V, Tjai M, Kong SC, Schwender B, Chan W, Shim HH, Khor CC, Cheung YB, Chowbay B. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients; oral presentation; APAGE 2016
HH Shim, GBB Goh, C Kwan, SY Lim, NKK Venkatanarasimha, RA Bakar, DSM Lau, TL Krishnamoorthy, KH Tay, WC Chow. Perceptions of Non Alcoholic Fatty Liver Disease – A Community Based Study; poster abstract; Asian Pacific Digestive Week (APDW) 2015
WPW Chan, HH Shim, SF Leila Bahjin, SP Isaac, SW Chuah, CSC Kong. Relationship between psychological factors and inflammatory bowel disease-related disability in Singapore; poster abstract; United European Gastroenterology Week (UEGW) 2015
Koay DSC., Salazar E., Tan CK., Chang JPE., Ong WC., Shim HH., Ngu JH. Autoimmune Hepatitis in Singapore: High prevalence of drug-induced cases secondary to herbal medicine; poster abstract; Digestive Disease Week (DDW) 2015
Koay DSC., Salazar E., Tan CK., Chang JPE., Ong WC., Shim HH., Ngu JH. High incidence of drug-induced autoimmune hepatitis secondary to herbal medicine in Singapore; poster abstract; Asian Pacific Association for the Study of the Liver (APASL) 2015
XY Li, BB Goh, HH Shim, YH Loh, WC Chow. Fructose intake and dietary habits in patients with non-alcoholic fatty liver disease; Oral presentation; SingHealth Duke-NUS Scientific Congress 2014
Shim HH, Salazar E, Chuah SW, Ling K, Thia K,Ooi CJ, Kong SC. Study of the significance between thiopurine induced lymphopenia and inflammatory bowel disease relapses; poster abstract; Asian Pacific Digestive Week (APDW)/ World Congress of Gastroenterology (WCG) 2013*Joint co-first author